Next New Releases from NCBI BookshelfPembrolizumab (Keytruda): Indication: For the treatment of adult patients with primary advanced or recurrent endometrial carcinoma, in combination with carboplatin and paclitaxel and then continued as monotherapy: Reimbursement Recommendation [Internet].Pembrolizumab (Keytruda): Indication: For the treatment of adult patients with primary advanced or recurrent endometrial carcinoma, in combination with carboplatin and paclitaxel and then continued as monotherapy: Reimbursement Recommendation [Internet].
